Literature DB >> 9512179

Estimation of the avidity of immunoglobulin G for routine diagnosis of chronic Toxoplasma gondii infection in pregnant women.

G J Cozon1, J Ferrandiz, H Nebhi, M Wallon, F Peyron.   

Abstract

Present serological methods differentiate poorly between acute and chronic toxoplasmosis in pregnant women, particularly when immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies to Toxoplasma gondii are present simultaneously. In the present study, a simple test for discriminating between high-avidity antibodies, which are usually present in chronic infections, and low-avidity antibodies, typical of acute infection, was evaluated. Sera were evaluated for Toxoplasma gondii antibodies using a commercial enzyme immunoassay, but a duplicate well was washed in 6M urea to disrupt low-avidity complexes. Results are expressed as the percentage of antibodies resisting elution by urea. Equivocal sera (n = 493) containing both IgG and IgM Toxoplasma gondii antibodies from 309 pregnant women whose status as chronically or acutely infected had been independently determined using standard methods were evaluated for antibody avidity. A value of > 35% elution-resistant antibodies was always associated with chronic infection and could absolutely exclude a recent (< 3 months) infectious incident. Values of < 35% require repeat testing four weeks later to confirm the patient's status, since a proportion of individuals with chronic toxoplasmosis maintain low-avidity antibodies over long periods. This inexpensive, simple method can provide reassurance to clearly chronically infected individuals and avoids the need for repeated testing in these cases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9512179     DOI: 10.1007/bf01584360

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  24 in total

1.  Single point quantification of antibody by ELISA without need of a reference curve.

Authors:  H D Dopatka; B Giesendorf
Journal:  J Clin Lab Anal       Date:  1992       Impact factor: 2.352

2.  IgA antibodies against P30 as markers of congenital and acute toxoplasmosis.

Authors:  A Decoster; F Darcy; A Caron; A Capron
Journal:  Lancet       Date:  1988-11-12       Impact factor: 79.321

3.  Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii.

Authors:  B R Dannemann; W C Vaughan; P Thulliez; J S Remington
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

Review 4.  Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?

Authors:  T G Wegmann; H Lin; L Guilbert; T R Mosmann
Journal:  Immunol Today       Date:  1993-07

Review 5.  Toxoplasmosis in pregnancy.

Authors:  S Y Wong; J S Remington
Journal:  Clin Infect Dis       Date:  1994-06       Impact factor: 9.079

6.  Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity.

Authors:  G Desmonts; J S Remington
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

7.  Use of acute-stage-specific antigens of Toxoplasma gondii for serodiagnosis of acute toxoplasmosis.

Authors:  Y Suzuki; P Thulliez; J S Remington
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

8.  An improved assay for the detection of Toxoplasma gondii antibodies in human serum by flow cytometry.

Authors:  G Cozon; C Roure; G Lizard; T Greenland; D Larget-Piet; F Gandilhon; F Peyron
Journal:  Cytometry       Date:  1993

9.  The diagnosis of toxoplasmosis using IgG avidity.

Authors:  R E Holliman; R Raymond; N Renton; J D Johnson
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

10.  Role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis.

Authors:  S Y Wong; M P Hajdu; R Ramirez; P Thulliez; R McLeod; J S Remington
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

View more
  27 in total

1.  Lack of utility of specific immunoglobulin G antibody avidity for serodiagnosis of reactivated toxoplasmosis in immunocompromised patients.

Authors:  B Mechain; Y J Garin; F Robert-Gangneux; J Dupouy-Camet; F Derouin
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

2.  VIDAS test for avidity of Toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women.

Authors:  Jose G Montoya; Oliver Liesenfeld; Sandra Kinney; Cynthia Press; Jack S Remington
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

3.  Impact of spiramycin treatment and gestational age on maturation of Toxoplasma gondii immunoglobulin G avidity in pregnant women.

Authors:  M Lefevre-Pettazzoni; A Bissery; M Wallon; G Cozon; F Peyron; M Rabilloud
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

4.  A study on the status of inflammatory systems in camels naturally infected with Toxoplasma gondii.

Authors:  Fatemeh Azma; Seyed Mostafa Razavi; Saeed Nazifi; Ehsan Rakhshandehroo; Ahmad Reza Sanati
Journal:  Trop Anim Health Prod       Date:  2015-04-07       Impact factor: 1.559

5.  Help in the Choice of Automated or Semiautomated Immunoassays for Serological Diagnosis of Toxoplasmosis: Evaluation of Nine Immunoassays by the French National Reference Center for Toxoplasmosis.

Authors:  O Villard; B Cimon; C L'Ollivier; H Fricker-Hidalgo; N Godineau; S Houze; L Paris; H Pelloux; I Villena; E Candolfi
Journal:  J Clin Microbiol       Date:  2016-10-12       Impact factor: 5.948

Review 6.  Delayed maturation of immunoglobulin G avidity: implication for the diagnosis of toxoplasmosis in pregnant women.

Authors:  M Lefevre-Pettazzoni; S Le Cam; M Wallon; F Peyron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-11       Impact factor: 3.267

7.  Cellular immunity to Toxoplasma gondii in congenitally infected newborns and immunocompetent infected hosts.

Authors:  A F Fatoohi; G J N Cozon; M Wallon; S Kahi; F Gay-Andrieu; T Greenland; F Peyron
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-04       Impact factor: 3.267

8.  Reliability of immunoglobulin G antitoxoplasma avidity test and effects of treatment on avidity indexes of infants and pregnant women.

Authors:  Pierre Flori; Laetitia Tardy; Hugues Patural; Bahrie Bellete; Marie-Noëlle Varlet; Jamal Hafid; Hélène Raberin; Roger Tran Manh Sung
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

9.  Usefulness of immunoblotting and Goldmann-Witmer coefficient for biological diagnosis of toxoplasmic retinochoroiditis.

Authors:  F Robert-Gangneux; P Binisti; D Antonetti; A Brezin; H Yera; J Dupouy-Camet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-12-11       Impact factor: 3.267

10.  Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy.

Authors:  Elisa Beghetto; Wilma Buffolano; Andrea Spadoni; Mariassunta Del Pezzo; Manlio Di Cristina; Olga Minenkova; Eskild Petersen; Franco Felici; Nicola Gargano
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.